Daniel H Buitrago, MD

Research Fellow

Daniel H Buitrago, MD

Research Fellow

Start Year


End Year


Current Employment

  • Surgical Resident, Beth Israel Deaconess Medical Center, Boston, MA.


  • Eguchi T, Bains S, Lee MC, Tan KS, Hristov B, Buitrago DH, Bains MS, Downey RJ, Huang J, Isbell JM, Park BJ, Rusch VW, Jones DR, Adusumilli PS*. Impact of increasing age on cause-specific mortality and morbidity in patients with stage I non-small c ell lung cancer: a competing risks analysis. J Clin Oncol. 2017;35(3):281-90.
  • Ujiie H, Kadota K, Chaft JE, Buitrago DH, Sima CS, Lee MC, Huang J, Travis WD, Rizk NP, Rudin CM, Jones DR, Adusumilli PS*. Solid predominant histologic subtype in resected stage I lung adenocarcinoma is an independent predictor of early, extrathoracic, multisite recurrence and of poor postrecurrence survival. J Clin Oncol. 2015;33(26):2877-84.
  • Kadota K, Nitadori J, Ujiie H, Buitrago DH, Woo KM, Sima CS, Travis WD, Jones DR, Adusumilli PS*. Prognostic impact of immune microenvironment in lung squamous cell carcinoma: tumor-infiltrating CD10+ neutrophil/CD20+ lymphocyte ratio as an independent prognostic factor. J Thorac Oncol. 2015;10(9):1301-10.
  • Kadota K, Buitrago DH, Lee MC, Villena-Vargas J, Sima CS, Jones DR, Travis WD, Adusumilli PS*. Tumoral CD10 expression correlates with high-grade histology and increases risk of recurrence in patients with stage I lung adenocarcinoma. Lung Cancer. 2015;89(3):329-36. 
  • Ahmad U, Yang H, Sima C, Buitrago DH, Ripley RT, Suzuki K, Bains MS, Rizk NP, Rusch VW, Huang J, Adusumilli PS, Rocco G, Jones DR. Resection of primary and secondary tumors of the sternum: an analysis of prognostic variables. Ann Thorac Surg. 2015;100(1):215-21; discussion 21-2.
  • Buitrago DH, Patnaik SK, Kadota K, Kannisto E, Jones DR, Adusumilli PS*. Small RNA sequencing for profiling microRNAs in long-term preserved formalin-fixed and paraffin-embedded non-small cell lung cancer tumor specimens. PLoS One. 2015;10(3):e0121521.
  • Lee MC, Buitrago DH, Kadota K, Ujiie H, Woo K, Sima CS, Travis WD, Jones DR, Adusumilli PS*. The tumor immune microenvironment in octogenarians with stage I non-small cell lung cancer. Oncoimmunology. 2014;3(11):e967142.
  • Lee MC, Kadota K, Buitrago DH, Jones DR, Adusumilli PS*. Implementing the new IASLC/ATS/ERS classification of lung adenocarcinomas: results from international and Chinese cohorts. J Thorac Dis. 2014;6(Suppl 5):S568-80.
  • Lee MC, Buitrago DH, Kadota K, Jones DR, Adusumilli PS*. Recent advances and clinical implications of the micropapillary histological subtype in lung adenocarcinomas. Lung Cancer Manag. 2014;3(3):245-53.